Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OraSure Technologies, Inc. - Common Stock (NQ:OSUR)

3.175 +0.095 (+3.08%)
Streaming Delayed Price Updated: 1:56 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 332,994
Open 3.060
Bid (Size) 3.170 (700)
Ask (Size) 3.180 (1,200)
Prev. Close 3.080
Today's Range 3.060 - 3.195
52wk Range 2.080 - 4.220
Shares Outstanding 73,262,370
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OraSure Technologies Inc (NASDAQ:OSUR) Reports Mixed Q4 2025 Results Amid Strategic Transition ↗
Via Chartmill
News headline image
OraSure Announces Fourth Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire

Performance

YTD
+33.4%
+33.4%
1 Month
+16.3%
+16.3%
3 Month
+33.4%
+33.4%
6 Month
-3.5%
-3.5%
1 Year
+3.8%
+3.8%

More News

Read More
News headline image
OraSure to Launch OraQuick™ HIV Self-Test in Canada
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
Via Benzinga
News headline image
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
From Altai Capital Management, L.P.
Via Business Wire
News headline image
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors
From Altai Capital Management, L.P.
Via Business Wire
News headline image
OraSure to Participate in Upcoming Investor Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure (OSUR) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
OraSure Announces Third Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Hedge Fund Reportedly Prepares To Launch Board Fight At OraSure Technologies: Retail Investors Believe It’s Good News ↗
Via Stocktwits
News headline image
OraSure Receives Warning From Ron Zwanziger: Entrepreneur Warns Of Adversarial Path If Board Continues To Refuse Buyout Offer ↗
Via Stocktwits
News headline image
OraSure (OSUR) Q2 Revenue Falls 43% ↗
Via The Motley Fool
Topics Economy
News headline image
OraSure Announces Second Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Appoints Anne Messing as Chief Commercial Officer
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Launches Novel Blood Collection Device for Proteomic Research
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing
From Targeted Genomics
Via GlobeNewswire
News headline image
OraSure Announces First Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is OraSure Technologies, Inc. - Common Stock publicly traded?
Yes, OraSure Technologies, Inc. - Common Stock is publicly traded.
What exchange does OraSure Technologies, Inc. - Common Stock trade on?
OraSure Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OraSure Technologies, Inc. - Common Stock?
The ticker symbol for OraSure Technologies, Inc. - Common Stock is OSUR on the Nasdaq Stock Market
What is the current price of OraSure Technologies, Inc. - Common Stock?
The current price of OraSure Technologies, Inc. - Common Stock is 3.175
When was OraSure Technologies, Inc. - Common Stock last traded?
The last trade of OraSure Technologies, Inc. - Common Stock was at 02/27/26 01:56 PM ET
What is the market capitalization of OraSure Technologies, Inc. - Common Stock?
The market capitalization of OraSure Technologies, Inc. - Common Stock is 232.61M
How many shares of OraSure Technologies, Inc. - Common Stock are outstanding?
OraSure Technologies, Inc. - Common Stock has 233M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.